Krempa David

Chief Business OfficerEton Pharmaceuticals, Inc. (ETON) · full profile →Form 4 · filed Jun 16, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$504K
Net Open-Market Flow
-$504K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 16, 2025Sell(S)10K$14.73$151K613K
Jun 13, 2025Sell(S)7K$14.77$100K623K
Jun 12, 2025Sell(S)17K$14.92$253K630K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-25-020518) within minutes of acceptance. Every field above traces to the original document. Verify it directly: